Oncolines at ENA 2026

Nov 18–20, 2026 Barcelona, Spain ~1.5k attendees Website

Oncolines brings 3 presentations to ENA 2026 in Barcelona. Its posters use large cancer cell line panels and combination screens to study resistance to antibody-drug conjugates and KRASG12C inhibitors. It also presents molecular glue stabilization of the β-catenin/14-3-3 interaction as a way to modulate Wnt signaling.

OrganizationENA 2026 Attendance
Oncolines
Oss, Netherlands
CROs & CDMOs
Precision medicine services company profiling cancer drugs across large cell line panels.

Explore the full ENA 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Barcelona. Leave your work email and we’ll be in touch.

Privacy

Download the full ENA 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Oncolines

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by EORTC, the NCI or the AACR. Submit a correction